Vericel Corp (VCEL)
47.83
-0.05
(-0.10%)
USD |
NASDAQ |
May 03, 16:00
47.81
-0.02
(-0.04%)
After-Hours: 20:00
Vericel Cash from Investing (Quarterly): -8.088M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.088M |
| September 30, 2023 | 4.566M |
| June 30, 2023 | -2.408M |
| March 31, 2023 | 2.80M |
| December 31, 2022 | -21.73M |
| September 30, 2022 | -0.811M |
| June 30, 2022 | -2.997M |
| March 31, 2022 | -10.67M |
| December 31, 2021 | 1.885M |
| September 30, 2021 | -2.629M |
| June 30, 2021 | -14.94M |
| March 31, 2021 | 12.19M |
| December 31, 2020 | -25.68M |
| September 30, 2020 | -17.44M |
| June 30, 2020 | 12.21M |
| March 31, 2020 | 13.74M |
| December 31, 2019 | -14.60M |
| September 30, 2019 | 13.37M |
| June 30, 2019 | -3.811M |
| March 31, 2019 | 15.66M |
| December 31, 2018 | -20.45M |
| September 30, 2018 | -45.60M |
| June 30, 2018 | -0.795M |
| March 31, 2018 | -0.184M |
| December 31, 2017 | -0.718M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.519M |
| June 30, 2017 | -0.203M |
| March 31, 2017 | -0.07M |
| December 31, 2016 | -0.101M |
| September 30, 2016 | -0.333M |
| June 30, 2016 | -1.061M |
| March 31, 2016 | 0.08M |
| December 31, 2015 | -0.097M |
| September 30, 2015 | -0.775M |
| June 30, 2015 | -1.202M |
| March 31, 2015 | -0.318M |
| December 31, 2014 | -0.646M |
| September 30, 2014 | -2.568M |
| June 30, 2014 | 1.036M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | -0.022M |
| March 31, 2013 | -0.018M |
| December 31, 2012 | -0.104M |
| September 30, 2012 | -0.083M |
| June 30, 2012 | -0.004M |
| March 31, 2012 | -0.082M |
| December 31, 2011 | -0.228M |
| September 30, 2011 | -0.391M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-25.68M
Minimum
Dec 2020
13.74M
Maximum
Mar 2020
-3.423M
Average
-2.629M
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
| ANI Pharmaceuticals Inc | -4.779M |
| Arbutus Biopharma Corp | 22.22M |
| Chimerix Inc | 28.07M |
| Karyopharm Therapeutics Inc | 26.84M |
| Y-mAbs Therapeutics Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 10.09M |
| Cash from Financing (Quarterly) | 1.307M |
| Free Cash Flow | 7.798M |
| Free Cash Flow Per Share (Quarterly) | 0.0471 |
| Free Cash Flow to Equity (Quarterly) | 2.251M |
| Free Cash Flow to Firm (Quarterly) | 2.251M |
| Free Cash Flow Yield | 0.34% |